Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Promise and Challenges of T Cell Immunotherapy for Osteosarcoma
Jeong A Park, Nai‐Kong V. Cheung
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12520-12520
Open Access | Times Cited: 18

Showing 18 citing articles:

Prospects and challenges of CAR-T cell therapy combined with ICIs
Yufan Lv, Xinyu Luo, Zhuoyi Xie, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 18
Digging Through the Complexities of Immunological Approaches in Emerging Osteosarcoma Therapeutics: A Comprehensive Narrative Review with Updated Clinical Trials
Consolato Sergi, Mervin Burnett, Eugeniu Jantuan, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 664-664
Open Access | Times Cited: 1
New insights into the mechanisms of the immune microenvironment and immunotherapy in osteosarcoma
Cong Luo, Xiaoyun Min, Danying Zhang
Frontiers in Immunology (2025) Vol. 15
Open Access
Long noncoding RNA DHRS4 antisense RNA 1 suppresses osteosarcoma cell proliferation and promotes apoptosis through a competitive endogenous RNA mechanism
Zhouzhou Tang, Zhihao Li, Guofeng Wu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Tumor-Associated Extracellular Matrix Obstacles for CAR-T Cell Therapy: Approaches to Overcoming
Ilya Klabukov, Alexander E. Kabakov, A. O. Yakimova, et al.
Current Oncology (2025) Vol. 32, Iss. 2, pp. 79-79
Open Access
Bibliometric analysis of targeted immunotherapy for osteosarcoma-current knowledge, hotspots and future perspectives
Yunxiang Hu, Rui Yang, Shuai Ni, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
SETDB1 amplification in osteosarcomas: Insights from its role in healthy tissues and other cancer types
E. Verdier, Nathalie Gaspar, Maria Eugénia Marques Da Costa, et al.
Oncotarget (2025) Vol. 16, Iss. 1, pp. 51-62
Open Access
Activation of pyroptosis and immunogenic cell death by targeted liposomal cisplatin for enhanced chemo-immunotherapy for osteosarcoma
Jingyou Bi, Yuchen Han, Xin-Li Han, et al.
Nano Today (2025) Vol. 62, pp. 102717-102717
Closed Access
Principles of Immunotherapy and Novel Immunotherapeutic Agents for Pediatric Cancer Management
Zachary Morrison, Ali Suliman
(2025), pp. 1-12
Closed Access
Advancements in Osteosarcoma Therapy: Overcoming Chemotherapy Resistance and Exploring Novel Pharmacological Strategies
Mahmoud Zhra, Shahid Akhtar Akhund, Khalid S. Mohammad
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 520-520
Open Access
Glypican-3 regulated epithelial mesenchymal transformation-related genes in osteosarcoma: based on comprehensive tumor microenvironment profiling
Jiaming Zhang, Wei Wang
Frontiers in Immunology (2025) Vol. 16
Open Access
Screening and identification Hub genes associated with immune cell infiltration and critical biomarkers in osteosarcoma
Xin Song, S Chen, Junning Cheng, et al.
Molecular and Cellular Probes (2025), pp. 102031-102031
Open Access
Novel cryopreservation medium for enhanced stability of T cells at −80°C
WenXuan Zhou, Chen Wang, Yao Shi, et al.
Frontiers in Hematology (2024) Vol. 3
Open Access | Times Cited: 2
CXCL6-CXCR2 axis-mediated PD-L2+ mast cell accumulation shapes the immunosuppressive microenvironment in osteosarcoma
Chengguang Wang, Zhenbin Lei, Chuanzhi Zhang, et al.
Heliyon (2024) Vol. 10, Iss. 14, pp. e34290-e34290
Open Access | Times Cited: 2
Solute carrier family 35 member A2 regulates mitophagy through the PI3K/AKT/mTOR axis, promoting the proliferation, migration, and invasion of osteosarcoma cells
Xiaohui Luo, Jiongfeng Zhang, Chong Guo, et al.
Gene (2023) Vol. 898, pp. 148110-148110
Closed Access | Times Cited: 6
Multi-omic validation of the cuproptosis-sphingolipid metabolism network: modulating the immune landscape in osteosarcoma
Qingbiao Li, Jiarui Fang, Kai Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Neoadjuvant Chemotherapy for Adults with Osteogenic Sarcoma
Michael J. Robinson, Elizabeth J. Davis
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 11, pp. 1366-1373
Open Access | Times Cited: 1
Targeting myeloid-derived suppressor cells in the tumor microenvironment: potential therapeutic approaches for osteosarcoma
Hye In Ka, Se Hwan Mun, Sora Han, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 33, Iss. 3, pp. 519-531
Closed Access | Times Cited: 1
Spatial multiplexed immunofluorescence analysis reveals coordinated cellular networks associated with overall survival in metastatic osteosarcoma
Ryan A. Lacinski, Sebastian A. Dziadowicz, Vincent K Melemai, et al.
Bone Research (2024) Vol. 12, Iss. 1
Open Access
Machine Learning Screening for Disulfidptosis Genes-Associated Immunosuppression Status in Osteosarcoma and Rhabdomyosarcoma
RuiZong Wang, J. Zhang, Kai Zhong, et al.
(2023)
Closed Access
Page 1

Scroll to top